Αρχειοθήκη ιστολογίου

Τρίτη 25 Ιουλίου 2017

Everolimus for Treatment of Pseudomyogenic Hemangioendothelioma

We describe a case of a 15-year-old boy with metastatic PMH, who responded to treatment with everolimus, a mammalian target of rapamycin inhibitor. Immunohistochemistry showed that mammalian target of rapamycin was expressed in PMH biopsy specimens, which may explain the reduction in PMH tumor size following treatment. (Source: Journal of Pediatric Hematology Oncology)

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2uUCU5y
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,

Αναζήτηση αυτού του ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader